Nationwide Fund Advisors’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
Other funds holding CORT
ISL
CCM
Nationwide Fund Advisors's CORT Position: Q4 2017 in Review
Nationwide Fund Advisors sold out of Corcept Therapeutics (CORT) in Q4 2017, closing a stake of 50,615 shares — an estimated $977K sold.
Nationwide Fund Advisors first reported a position in CORT in Q2 2013 and held it in 18 quarters. The position peaked at $977K in Q3 2017. 190 funds tracked by Wall St. Rank hold CORT as of Q4 2017.
- Nationwide Fund Advisors reported no remaining Corcept Therapeutics position as of Q4 2017 after selling out during the quarter.
- Nationwide Fund Advisors sold 50,615 Corcept Therapeutics shares in Q4 2017, an estimated $977K.
- Nationwide Fund Advisors first reported a position in Corcept Therapeutics in Q2 2013 and held it in 18 quarters.
- Nationwide Fund Advisors's Corcept Therapeutics position peaked at $977K in Q3 2017.
- 190 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q4 2017.
Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.